Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-08-16
2005-08-16
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
06930108
ABSTRACT:
The present invention relates to the use of known 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position and cGMP PDE-inhibitory properties for the production of medicaments for the treatment of cardiac insufficiency, psoriasis, female infertility, cancer, diabetes, ophthalmic disorders such as glaucoma, disorders of gastric motility, cystic fibrosis, premature labour, pulmonary hypertension, bladder disorders, prostate hyperplasia, nitrate-induced tolerance, pre-eclampsia, alopecia, Parkinson's disease, pain, tinnitus or the renal syndrome.
REFERENCES:
patent: 6362178 (2002-03-01), Niewohner et al.
patent: 594671 (1978-01-01), None
patent: 2255172 (1973-05-01), None
patent: 2364076 (1974-07-01), None
patent: 2811780 (1978-09-01), None
patent: 0009384 (1980-04-01), None
patent: 1092719 (2001-04-01), None
patent: 1097711 (2001-05-01), None
patent: 2213058 (1974-02-01), None
patent: 9428902 (1994-12-01), None
patent: 9924433 (1999-05-01), None
patent: 9967244 (1999-12-01), None
patent: 02064593 (2002-08-01), None
Cecil Textbook of Medicine, 21stEd. vol. 1, Goldman et al. (eds.), published 2000 by W.B.Saunders Co., pp 1060-1074.
Beavo, et al., “Primary Sequence of Cyclic Nucleotide Phosphodiesterase Isozymes and the Design of Selective Inhibitors,”TIPS Reviews, 11, 150-155 (1990).
Fawcett, et al., “Molecular Cloning and Characterization of a Distinct Human Phosphodiesterase Gene Family: PDE11A,”Proc. Nat. Acad. Sci., 97(7), 3702-3707 (2000).
Stoclet, et al., “Cyclic Nucleotide Phosphodiesterases as Therapeutic Targets in Cardiovascular Diseases,”Exp. Opin. Invest. Drugs, 4(11), 1081-1100 (1995).
Masatoshi Miyahara, Isoenzymes of cyclic nucleotide phosphodiesterase in the human aorta: Characterization and the effects of E4021, European Journal of Pharmacology 384 (1995) 25-33.
Bandel Tiemo-Joerg
Barth Wolfgang
Bischoff Erwin
Haning Helmut
Niewöhner Maria Theresia
Bayer HealthCare AG
Henley III Raymond J.
Pellegrino Susan M.
LandOfFree
Use of 2-alkoxyphenol-substituted imidazotriazinones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 2-alkoxyphenol-substituted imidazotriazinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 2-alkoxyphenol-substituted imidazotriazinones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3517496